These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 12758280)

  • 21. In vivo and in vitro phagocytosis of Leishmania (Leishmania) amazonensis promastigotes by B-1 cells.
    Geraldo MM; Costa CR; Barbosa FM; Vivanco BC; Gonzaga WF; Novaes E Brito RR; Popi AF; Lopes JD; Xander P
    Parasite Immunol; 2016 Jun; 38(6):365-76. PubMed ID: 27084328
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The relationship of Leishmania braziliensis subspecies and immune response to disease expression in New World leishmaniasis.
    Saravia NG; Valderrama L; Labrada M; Holguín AF; Navas C; Palma G; Weigle KA
    J Infect Dis; 1989 Apr; 159(4):725-35. PubMed ID: 2647862
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Killing of Leishmania tropica amastigotes by factors in normal human serum.
    Hoover DL; Berger M; Nacy CA; Hockmeyer WT; Meltzer MS
    J Immunol; 1984 Feb; 132(2):893-7. PubMed ID: 6690622
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The host response to Leishmania infection.
    Solbach W; Laskay T
    Adv Immunol; 2000; 74():275-317. PubMed ID: 10605608
    [No Abstract]   [Full Text] [Related]  

  • 25. IgE antibody against surface antigens of Leishmania promastigotes in American cutaneous leishmaniasis.
    Lynch NR; Malavé C; Turner KJ; Infante B
    Parasite Immunol; 1986 Mar; 8(2):109-16. PubMed ID: 3517764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Leishmania, the phagosome, and host responses: The journey of a parasite.
    Séguin O; Descoteaux A
    Cell Immunol; 2016 Nov; 309():1-6. PubMed ID: 27531526
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Recognition of the major cell surface glycoconjugates of Leishmania parasites by the human serum mannan-binding protein.
    Green PJ; Feizi T; Stoll MS; Thiel S; Prescott A; McConville MJ
    Mol Biochem Parasitol; 1994 Aug; 66(2):319-28. PubMed ID: 7808481
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Leishmania promastigotes require opsonic complement to bind to the human leukocyte integrin Mac-1 (CD11b/CD18).
    Mosser DM; Springer TA; Diamond MS
    J Cell Biol; 1992 Jan; 116(2):511-20. PubMed ID: 1730765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Leishmania amastigotes: resistance to complement-mediated lysis is not due to a failure to fix C3.
    Mosser DM; Wedgwood JF; Edelson PJ
    J Immunol; 1985 Jun; 134(6):4128-31. PubMed ID: 3886796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Potential biomarkers of immune protection in human leishmaniasis.
    Rostami MN; Khamesipour A
    Med Microbiol Immunol; 2021 Jun; 210(2-3):81-100. PubMed ID: 33934238
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mechanism of lethal effect of human serum upon Leishmania donovani.
    Pearson RD; Steigbigel RT
    J Immunol; 1980 Nov; 125(5):2195-201. PubMed ID: 7430624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leishmania (Leishmania) amazonensis infection and dissemination in mice inoculated with stationary-phase or with purified metacyclic promastigotes.
    Felizardo TC; Toma LS; Borges NB; Lima GM; Abrahamsohn IA
    Parasitology; 2007 Nov; 134(Pt 12):1699-707. PubMed ID: 17655808
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum resistance of metacyclic stage Leishmania major promastigotes is due to release of C5b-9.
    Puentes SM; Da Silva RP; Sacks DL; Hammer CH; Joiner KA
    J Immunol; 1990 Dec; 145(12):4311-6. PubMed ID: 2147941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cationic liposomes formulated with a novel whole Leishmania lysate (WLL) as a vaccine for leishmaniasis in murine model.
    Jafari I; Heravi Shargh V; Shahryari M; Abbasi A; Jaafari MR; Khamesipour A; Badiee A
    Immunobiology; 2018; 223(6-7):493-500. PubMed ID: 29317110
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential phagocytosis of Leishmania mexicana promastigotes and amastigotes by monocyte-derived dendritic cells.
    Argueta-Donohué J; Wilkins-Rodríguez AA; Aguirre-García M; Gutiérrez-Kobeh L
    Microbiol Immunol; 2016 Jun; 60(6):369-81. PubMed ID: 26399218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serodiagnosis of leishmaniasis.
    Kar K
    Crit Rev Microbiol; 1995; 21(2):123-52. PubMed ID: 7639932
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The third component of complement (C3) is responsible for the intracellular survival of Leishmania major.
    Mosser DM; Edelson PJ
    Nature; 1987 May 28-Jun 3; 327(6120):329-31. PubMed ID: 3035377
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibodies to Leishmania tropica promastigotes during infection in mice of various genotypes.
    Olobo JO; Handman E; Curtis JM; Mitchell GF
    Aust J Exp Biol Med Sci; 1980 Dec; 58(6):595-601. PubMed ID: 7271598
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The interface between the Leishmania-infected macrophage and the host's immune system.
    Russell DG; Medina-Acosta E; Golubev A
    Behring Inst Mitt; 1991 Feb; (88):68-79. PubMed ID: 2049048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum antibody specificities to Leishmania aethiopica antigens in patients with localized and diffuse cutaneous leishmaniasis.
    Mengistu G; Akuffo HO; Yemane-Berhan T; Britton S; Fehniger TE
    Parasite Immunol; 1990 Sep; 12(5):495-507. PubMed ID: 2255561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.